Comparing Dupilumab vs Fasenra
| Dupilumab | Fasenra (benralizumab) |
|
|---|
| Dupilumab | Fasenra (benralizumab) |
|
|---|---|---|
|
Prescription only
Prescribed for Eosinophilic Esophagitis, Chronic Rhinosinusitis With Nasal Polyps, Prurigo Nodularis, Eczema, Atopic Dermatitis, Asthma, Asthma - Maintenance, Bullous Pemphigoid, COPD, Urticaria... View more |
Prescription only
[Fasenra](https://www.drugs.com/fasenra.html) is a biologic that may be used to treat severe eosinophilic asthma in adults and children aged 6 years and older or eosinophilic granulomatosis with... View more |
Related suggestions Popular comparisons
|
| More about Dupilumab | More about Fasenra (benralizumab) | |
| Ratings & Reviews | ||
|
Dupilumab has an average rating of 7.3 out of 10 from a total of 542 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 19% reported a negative effect. |
Fasenra has an average rating of 7.8 out of 10 from a total of 76 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 16% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Dupilumab side effects |
View all Fasenra side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
|
|
| Brand Names | ||
| Dupixent |
N/A |
|
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
N/A |
360 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 97 drugs are known to interact with Dupilumab:
|
A total of 25 drugs are known to interact with Fasenra:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | ||
| First Approval Date | ||
|
N/A |
November 14, 2017 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Eohilia
Eohilia (budesonide) suspension is used to treat eosinophilic esophagitis (EoE), to reduce symptoms ...
Breztri Aerosphere
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the ...
Nucala
Nucala is used to treat severe eosinophilic asthma, eosinophilic COPD, chronic rhinosinusitis with ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Flovent
Flovent (fluticasone) is a corticosteroid used to prevent bronchial asthma attacks. Includes ...
Arnuity Ellipta
Arnuity Ellipta (fluticasone furoate) is used to treat asthma. Includes Arnuity Ellipta side ...
Flovent HFA
Flovent HFA is used for asthma, maintenance, bronchopulmonary dysplasia, eosinophilic esophagitis
Pulmicort Turbuhaler
Pulmicort (budesonide) is used to prevent asthma attacks. Includes Pulmicort side effects ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.